Search - tctmd.com

Displaying 1 - 20 of 40

Sort: Relevancy | Date

Carotid Stenting Makes a Strong Showing in the CREST-2 Registry

News Daily News

Carotid Stenting Makes a Strong Showing in the CREST-2 Registry

December 23, 2019

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

News Daily News

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Yael L. Maxwell

December 19, 2019

Apple Watch—and a Proactive Patient—Pick Up AV Block Post-TAVR

News Daily News

Apple Watch—and a Proactive Patient—Pick Up AV Block Post-TAVR

Yael L. Maxwell

December 16, 2019

FDA Approves Icosapent Ethyl for Reducing CVD Events

News Daily News

FDA Approves Icosapent Ethyl for Reducing CVD Events

Michael O'Riordan

December 13, 2019

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

News Daily News

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

December 06, 2019

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

News Daily News

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

November 27, 2019

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

News Conference News VEITH 2019

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

November 26, 2019

Could Revascularization of Carotid Stenosis Reverse Cognitive Deficits?

News Conference News VEITH 2019

Could Revascularization of Carotid Stenosis Reverse Cognitive Deficits?

November 25, 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

News Conference News PCR London Valves 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Michael O'Riordan

November 25, 2019

EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl

News Conference News AHA 2019

EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl

November 18, 2019

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most

News Daily News

Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most

Yael L. Maxwell

November 07, 2019

News Industry News

Penumbra Announces First Patient Enrolled In Study Of Mechanical Power Aspiration For Thrombus Removal In Coronary Vessels

October 10, 2019

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

News Conference News TCT 2019

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

Yael L. Maxwell

October 08, 2019

TCT 8: Updated 30-Day Outcomes for the U.S. Early Feasibility Study of the SAPIEN M3 Transcatheter Mitral Valve Replacement System

Presentation TCT 2019

TCT 8: Updated 30-Day Outcomes for the U.S. Early Feasibility Study of the SAPIEN M3 Transcatheter Mitral Valve Replacement System

Presenter: Brian Whisenant

September 28, 2019

TCT 2: Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement in Moderate Risk Patients: A Pooled PARTNER 2 Trial and Registry Study

Presentation TCT 2019

TCT 2: Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement in Moderate Risk Patients: A Pooled PARTNER 2 Trial and Registry Study

Presenter: Katherine Chau

September 28, 2019

TCT 5: Is Surgical Aortic Valve Replacement Still an Option for Radiation-induced Aortic Stenosis in Transcatheter Aortic Valve Replacement Era?

Presentation TCT 2019

TCT 5: Is Surgical Aortic Valve Replacement Still an Option for Radiation-induced Aortic Stenosis in Transcatheter Aortic Valve Replacement Era?

Presenter: Farhang Yazdchi

September 28, 2019

TCT 3: Modified Body Mass Index, a Novel Marker of Malnutrition and Clinical Frailty, is Associated with Outcomes after Transcatheter and Surgical Aortic Valve Replacement

Presentation TCT 2019

TCT 3: Modified Body Mass Index, a Novel Marker of Malnutrition and Clinical Frailty, is Associated with Outcomes after Transcatheter and Surgical Aortic Valve Replacement

Presenter: Elissa Driggin

September 28, 2019

TCT 7: Blinded Outcomes Assessment of Absorb Bioresorbable Scaffolds Implanted with Improved Technique: Two-year Results from the ABSORB IV Randomized Trial

Presentation TCT 2019

TCT 7: Blinded Outcomes Assessment of Absorb Bioresorbable Scaffolds Implanted With Improved Technique: Two-year Results From the ABSORB IV Randomized Trial

Presenter: Gregg Stone

September 28, 2019

TCT 1: A Novel Risk-Based Strategy in Adopting New Technology: Pilot Study Assessing Clinical and Quality Outcomes of Real World Intravascular Ultrasound (IVUS) and Instant Wave-Free Ratio (iFR) Utilization in a Unique Risk-Sharing Program

Presentation TCT 2019

TCT 1: A Novel Risk-Based Strategy in Adopting New Technology: Pilot Study Assessing Clinical and Quality Outcomes of Real World Intravascular Ultrasound (IVUS) and Instant Wave-Free Ratio (iFR) Utilization in a Unique Risk-Sharing Program

Presenter: Mark Chang

September 28, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.